Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Aug 11, 2025

Accession no.
0001628280-25-039400
Filed
Aug 11, 2025
Trade date
Jul 1-31, 2025
Filing delay
41 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 22 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.17K. It was filed 41 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2025Common StockPPurchaseAcquired+16$3.56+$56.965,699,444Direct
Jul 2, 2025Common StockPPurchaseAcquired+16$3.52+$56.325,699,460Direct
Jul 3, 2025Common StockPPurchaseAcquired+16$3.31+$52.965,699,476Direct
Jul 7, 2025Common StockPPurchaseAcquired+16$3.23+$51.685,699,492Direct
Jul 8, 2025Common StockPPurchaseAcquired+16$3.06+$48.965,699,508Direct
Jul 9, 2025Common StockPPurchaseAcquired+16$3.05+$48.85,699,524Direct
Jul 10, 2025Common StockPPurchaseAcquired+16$3.20+$51.25,699,540Direct
Jul 11, 2025Common StockPPurchaseAcquired+16$3.21+$51.365,699,556Direct
Jul 14, 2025Common StockPPurchaseAcquired+16$3.46+$55.365,699,572Direct
Jul 15, 2025Common StockPPurchaseAcquired+16$3.45+$55.25,699,588Direct
Jul 16, 2025Common StockPPurchaseAcquired+16$3.79+$60.645,699,604Direct
Jul 17, 2025Common StockPPurchaseAcquired+16$3.82+$61.125,699,620Direct
Jul 18, 2025Common StockPPurchaseAcquired+16$3.59+$57.445,699,636Direct
Jul 21, 2025Common StockPPurchaseAcquired+16$3.45+$55.25,699,652Direct
Jul 22, 2025Common StockPPurchaseAcquired+16$3.47+$55.525,699,668Direct
Jul 23, 2025Common StockPPurchaseAcquired+16$3.54+$56.645,699,684Direct
Jul 24, 2025Common StockPPurchaseAcquired+16$3.55+$56.85,699,700Direct
Jul 25, 2025Common StockPPurchaseAcquired+16$3.37+$53.925,699,716Direct
Jul 28, 2025Common StockPPurchaseAcquired+13$3.47+$45.115,699,729Direct
Jul 29, 2025Common StockPPurchaseAcquired+13$3.33+$43.295,699,742Direct
Jul 30, 2025Common StockPPurchaseAcquired+13$3.55+$46.155,699,755Direct
Jul 31, 2025Common StockPPurchaseAcquired+13$3.50+$45.55,699,768Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)